CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7,074 | $3,692 | $1,444 | $147 |
| Gross Profit | -$7,074 | -$3,692 | -$1,444 | -$147 |
| % Margin | – | – | – | – |
| R&D Expenses | $143,397 | $75,791 | $29,373 | $4,461 |
| G&A Expenses | $43,973 | $20,919 | $5,398 | $1,516 |
| SG&A Expenses | $43,973 | $17,227 | $5,398 | $1,516 |
| Sales & Mktg Exp. | $0 | -$3,692 | $0 | $0 |
| Other Operating Expenses | -$7,074 | $0 | -$1,444 | -$147 |
| Operating Expenses | $180,296 | $93,018 | $33,327 | $5,830 |
| Operating Income | -$187,370 | -$96,710 | -$34,771 | -$5,977 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $19,868 | -$1,437 | -$6,180 | $127 |
| Pre-Tax Income | -$167,502 | -$98,147 | -$40,951 | -$5,850 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$167,502 | -$98,147 | -$40,951 | -$5,850 |
| % Margin | – | – | – | – |
| EPS | -3.72 | -2.38 | -2.13 | -0.3 |
| % Growth | -56.3% | -11.7% | -610% | – |
| EPS Diluted | -3.72 | -2.38 | -2.13 | -0.3 |
| Weighted Avg Shares Out | 44,970 | 41,206 | 19,230 | 19,470 |
| Weighted Avg Shares Out Dil | 44,970 | 41,206 | 19,230 | 19,470 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20,063 | $0 | $0 | $0 |
| Interest Expense | $0 | $1,604 | $4,942 | $0 |
| Depreciation & Amortization | $7,074 | $3,692 | $1,444 | $147 |
| EBITDA | -$160,428 | -$93,018 | -$34,565 | -$5,703 |
| % Margin | – | – | – | – |